Home › Heart Failure › NCT06877169
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adult patients (18 years or older) undergoing combined heart and kidney transplantation at Cedars-Sinai Medical Center. Exclusion Criteria: * Patients who undergo simultaneous heart/kidney transplantation in a single operative event due to medical necessity will be excluded. * Patients with medical records flagged as "break-the-glass" or "research opt-out" within the center's electronic health record.
About the study
The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.
What is being tested
- Planned delayed implantation of kidney allograft with ex vivo machine perfusion kidney preservation. (other)
Sponsor: Cedars-Sinai Medical Center · Participants: 20 · Started: Apr 7, 2025
Contact the study team
- Justin A Steggerda, M.D. · Phone: 310-423-3276
Official record on ClinicalTrials.gov — NCT06877169
Locations in the U.S.
| California | Cedars-Sinai Medical Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.